Screenplay Option Agreement Explained: What You're Signing Away

Screenplay Option Agreement Explained: You Are Renting, Not Selling

Here is a screenplay option agreement explained without the ceremony. A producer pays you a fee for the exclusive right to try to get your script made, for a fixed stretch of time, at a purchase price the two of you agree on before anyone knows whether the film will ever happen. They are not buying the script. They are buying the right to buy it later, at a number locked in today.

That one distinction runs through every clause that follows. Ownership does not move on signing. What moves is control. For the length of the option period you cannot take the script anywhere else, and in exchange the producer can walk into a financier's office, or a director's agency, or an actor's manager, and say the sentence that makes the entire business function: I control this material. Without that sentence they cannot attach anyone, and without attachments there is no film. The option is the instrument that converts a script sitting on your drive into something another person can spend a year and a half of their credibility on.

One note before anything else, said once and then dropped. This is a plain reading of standard deal mechanics, not legal advice. Terms vary enormously between deals, and the draft that lands in your inbox was written by the other side's counsel to serve the other side.

The mental model that keeps writers out of trouble is a lease with a purchase clause. You are the landlord. The producer is a tenant with the right to buy the whole building at a price fixed on the day they moved in. The rent is small relative to the sale price precisely because most tenants never buy. If the tenant does buy, the sale terms are already settled and you have no second bite. If the tenant walks away, you get the keys back and you keep the rent, assuming you wrote the return of the keys into the paper in the first place.

Most of the real damage in option deals is not done by the fee being low. It is done by the parts of the building the writer did not realise were included in the lease: the sequel, the prequel, the television version, the stage adaptation, the reboot that arrives a decade later with a different writer's name on it.

The Two Numbers That Define Every Option: The Fee and the Period

Strip an option agreement down and two numbers do most of the work. How much, and how long.

The period. An option period typically runs 6 to 18 months. Inside that window the producer has exclusivity and you have a clock. Extensions commonly run a further 12 to 24 months, normally purchased with a second payment made before the current period lapses. Do the arithmetic on the whole structure rather than the headline. An agreement that presents itself as a twelve month deal on page one can, once every extension is exercised, tie up your script for the better part of three years. That is the number that matters to your career, because it is the number of years the script is unavailable to anyone else.

Who holds the extension right is usually the producer, unilaterally, and that is ordinary. What deserves resistance is an extension that renews without a fresh payment, or a rolling structure with no outer boundary at all. If you cannot point at a date on the calendar and say "on this day, at the latest, this is mine again," the period is not really defined.

The fee. The option fee is not a standalone figure. It is a percentage of the agreed purchase price, which is why the two numbers are welded together. Reported ranges vary widely depending on who is describing the market: as low as 1 to 3 percent, commonly quoted at 2.5 to 10 percent, and as high as 10 to 15 percent. That spread is itself the lesson. There is no settled rate. Where you land is a function of leverage: genuine competing interest, a track record, the producer's resources, and how badly they want to stop anyone else reading it.

The practical consequence of the fee being a percentage is that writers negotiate the wrong number. Push the purchase price up and the option fee rises with it, because it is calculated off that base. Push only on the fee and you have optimised the small cheque while leaving the large one alone. Ask early, in plain words, whether the option fee applies against the purchase price if the option is exercised, because that answer changes what the deal is actually worth.

What the Purchase Price Is Actually Tied To

Ask a writer what their script sold for and you get a figure. Read the agreement that produced it and you usually find a formula.

The purchase price is often calculated as a percentage of the film's total direct cost budget, subject to a floor and a ceiling, on a sliding scale. The logic is that the writer's payday should track the size of the production, so the price rises as the budget rises. The floor protects you if the picture is made for far less than anyone imagined at signing. The ceiling protects the producer if it balloons. Both of those numbers, floor and ceiling, are negotiated, and both are far more consequential than the percentage attached to them, because the percentage only ever operates in the space between.

The phrase carrying the most weight in that formula is "total direct cost," and its definition is itself a negotiated term. What counts, what is excluded, and who calculates it are questions your lawyer should be looking at closely, since a generous percentage of a narrowly defined budget can pay less than a modest percentage of a broadly defined one.

If you are a Guild member, part of this stops being guesswork, because the floor is published rather than invented. The most recently published Guild schedule puts the minimum for the sale or purchase of an original screenplay at $125,023 where the budget is $5,000,000 or more, and $61,064 where it is under $5,000,000, with the 2026 agreement adding 1.5 percent for contracts entered into on or after May 2, 2026. High budget means over $5,000,000, low budget means under it. There is also a specific rule for options: a WGA member must be paid an option fee of no less than 10 percent of the applicable WGA minimum purchase price, for a term not exceeding 18 months.

That rule is worth reading twice, because it does two jobs at once. It sets a price floor and it sets a time ceiling. Guild coverage is not a formality on a deal like this. It is the difference between a negotiation with a bottom and a negotiation without one.

If you are not a Guild member and the production is not a signatory, those numbers do not bind anyone. They still function as gravity. Everybody in the room knows what the minimums are, which makes them a reference point in a conversation that otherwise has none.

Reversion in a Screenplay Option Agreement Explained: How Your Script Comes Home

Reversion is the clause that decides whether a failed option costs you a year or costs you the script.

The base rule is mechanical and it belongs in every deal you sign. If the option expires without the producer either starting production or buying the script outright, the rights revert to you. Nothing dramatic happens. The clock runs out, control returns, you keep the fee, and you are free to take the material anywhere. That is the version of failure a writer can live with, and it is the version most people assume is automatic. Confirm that it is written down rather than assumed, and confirm that it operates on expiry rather than depending on some notice you are required to serve at the right moment through the right channel.

The second provision is sharper and it is the one writers forget to ask for. A writer can include a term triggering reversion if the producer buys the script but does not start shooting within a specified period. Without it, an exercised option is permanent. They own the material outright, they can put it on a shelf, and there is no route back for you no matter how many years pass with nothing happening. A purchase with no shooting obligation is the quietest way for a script to vanish, because on paper it looks like the best outcome you could have hoped for.

Think of the two provisions as covering two different deaths. The first covers the option that simply runs out. The second covers the option that succeeds and then stalls, which is the failure mode nobody warns first time sellers about.

Turnaround, and the Clause That Decides Whether a Dead Project Frees You

Turnaround is what the business calls it when a defect in the production causes the producer to abandon it. A major actor falls through and the financing that was contingent on that actor evaporates. Or the reason given is the frequently cited "creative differences," which is a phrase built specifically to explain nothing.

A writer may include a provision under which rights revert in turnaround, and that provision is the difference between a project that dies and a script that dies with it. These clauses are commonly triggered one of two ways: by a failure to commence principal photography within 12 to 24 months after the option is exercised, or by a broader failure to "actively develop" or "meaningfully exploit" the project.

Those two triggers behave very differently, and you want to understand why before you accept one of them alone.

The hard date is objective. Cameras rolled or they did not, on a date anyone can look up. It is easy to enforce and impossible to argue about, which is exactly why the other side will want it set as far out as possible. The soft standard is broader in theory, since a project can be plainly abandoned long before any shooting deadline arrives, but it is subjective in practice. A thin trail of emails, a general meeting, one set of notes on a draft, and a producer can make a decent argument that development is ongoing.

The sensible position is both. A hard outer date so there is a moment the clause fires regardless, and a development standard so you have an argument earlier if the project is visibly dead. Ask your lawyer to look specifically at what evidence the agreement treats as active development, because a clause that lets the other side define its own compliance is not much of a clause.

Sequels, Prequels, and the Rights You Did Not Mean to Give Away

This is the section where writers lose the most and notice the least, because the language that does it is boring and it sits in the middle of the grant clause where nobody's attention survives.

Option agreements often include direct sequels and prequels, plus "nearquels" extending across other platforms, and that reaches further than most writers expect: stage play adaptations, book adaptations, reboots. It arrives dressed as standard boilerplate, some version of all rights in and to the property, in all media now known or hereafter devised, throughout the universe, in perpetuity. Nothing in that sentence is a red flag on its own. Taken together, it hands over every future version of your story to a company that has not yet made the first one.

Here is what that costs. It has happened that the original property reverted to the writer while the sequel, prequel and nearquel rights stayed with the production company. Read that carefully, because it describes a specific and genuinely bad outcome: you win the reversion fight, you get your script back, and it is a script nobody can build anything on, because the entire downstream franchise belongs to somebody else. You own the house and they own every extension you might ever want to build on it.

The fix is structural rather than clever. Derivative rights should follow the underlying property. If reversion triggers, everything reverts together, sequels and prequels and adaptations included. Where that is a fight you cannot win, the fallback positions are to make the hold on derivative rights conditional on the picture actually being produced, or to put a time limit on how long those rights can sit unused before they come back to you. A production company that will not make derivative rights contingent on making the film is telling you something about how central the film is to their plan.

Passive Royalties: Getting Paid When Someone Else Writes It

Suppose the good version happens. The picture is made, it works, and the company wants a sequel, a remake, or a television adaptation. There is no rule that says you get to write it. Assignments go to whoever the studio and the producer want, for reasons that often have nothing to do with the quality of the original script.

Which is why writers should negotiate passive royalties: payments made to the writer when a subsequent production is made based on the picture, including a sequel, prequel, remake, or television adaptation, without the writer being engaged to write that subsequent production. The word doing the work is passive. You are paid because the thing exists and it came from your material, not because you were hired.

Passive royalties and derivative rights are the same conversation approached from opposite ends. The derivative rights question asks who owns the sequel. The passive royalty question asks what you receive if the sequel is made anyway. Writers who lose the first fight and skip the second have given away every future version of their story and arranged to be paid nothing for any of them.

Raise it early, while the deal still feels collaborative and everyone is enthusiastic. Passive royalties on a project nobody has financed are a cheap concession for a producer to make. The same request after the film is a success is a completely different conversation, and you will be having it from a much worse position.

Before You Sign Anything

Work through the paper with this list in front of you, in this order, because each item changes the meaning of the one after it.

The total time. Not the initial period. The initial period plus every extension the producer can exercise, expressed as a single number of months.

The fee and its base. What percentage of the purchase price it represents, and whether it applies against that price on exercise.

The purchase price formula. The percentage, the definition of total direct cost, and above all the floor and the ceiling, since those are the numbers you will actually live inside.

Reversion on expiry. Automatic, written down, not conditional on you performing some administrative step at the right moment.

Reversion after purchase. A shooting deadline attached to the exercise, so a completed sale cannot become a permanent shelf.

Turnaround. A hard date on principal photography, plus a development standard, and clarity about what evidence satisfies it.

Derivative rights. Sequels, prequels, nearquels, stage, book, reboot. Do they revert with the underlying property, and if not, when do they come back and on what condition.

Passive royalties. On every category of subsequent production the agreement contemplates.

One useful piece of calibration before you start. On a publisher like ScriptLix the reading price is published up front, so a buyer can see exactly what it includes before anyone talks money. A negotiated option is the opposite of that by design: nothing in it is standard until you have read the specific paper in front of you, and two agreements that look identical from across the table can allocate the same rights in completely different directions.

The standing advice, and the reason this list is a preparation tool rather than a substitute, is to have a lawyer review the agreement carefully, with particular attention to the single question that decides how the deal ends: which rights revert to you, and which stay with the producer. That question sits underneath reversion, turnaround, derivative rights and passive royalties all at once, and it is the one an experienced reader answers in ten minutes and a first time seller misreads for years.

None of this is an argument against optioning your script. An option is a producer betting real money and real time that they can get your film made, and that is the point at which a screenplay stops being a document and starts being a project. Sign it. Just sign it knowing that you have leased the building, that the lease has an end date you can name, and that everything you did not explicitly keep is something you agreed to hand over.